Skip to main content

Incidence of Major Bleeding in a Real-World Population of 57,070 Nonvalvular Atrial Fibrillation Patients Treated With Rivaroxaban

Publication ,  Conference
Peacock, F; Patel, M; Yuan, Z; Sicignano, N; Hopf, K; Tamayo, S
Published in: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
May 1, 2017

Duke Scholars

Published In

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

EISSN

1524-4636

ISSN

1079-5642

Publication Date

May 1, 2017

Volume

37

Location

Minneapolis, MN

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

American-Heart-Association's Arteriosclerosis, Thrombosis and Vascular Biology/Peripheral Vascular Disease Scientific Sessions

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Peacock, F., Patel, M., Yuan, Z., Sicignano, N., Hopf, K., & Tamayo, S. (2017). Incidence of Major Bleeding in a Real-World Population of 57,070 Nonvalvular Atrial Fibrillation Patients Treated With Rivaroxaban. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (Vol. 37). Minneapolis, MN: LIPPINCOTT WILLIAMS & WILKINS.
Peacock, Frank, Manesh Patel, Zhong Yuan, Nicholas Sicignano, Kathleen Hopf, and Sally Tamayo. “Incidence of Major Bleeding in a Real-World Population of 57,070 Nonvalvular Atrial Fibrillation Patients Treated With Rivaroxaban.” In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, Vol. 37. LIPPINCOTT WILLIAMS & WILKINS, 2017.
Peacock F, Patel M, Yuan Z, Sicignano N, Hopf K, Tamayo S. Incidence of Major Bleeding in a Real-World Population of 57,070 Nonvalvular Atrial Fibrillation Patients Treated With Rivaroxaban. In: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2017.
Peacock, Frank, et al. “Incidence of Major Bleeding in a Real-World Population of 57,070 Nonvalvular Atrial Fibrillation Patients Treated With Rivaroxaban.” ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, vol. 37, LIPPINCOTT WILLIAMS & WILKINS, 2017.
Peacock F, Patel M, Yuan Z, Sicignano N, Hopf K, Tamayo S. Incidence of Major Bleeding in a Real-World Population of 57,070 Nonvalvular Atrial Fibrillation Patients Treated With Rivaroxaban. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. LIPPINCOTT WILLIAMS & WILKINS; 2017.

Published In

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

EISSN

1524-4636

ISSN

1079-5642

Publication Date

May 1, 2017

Volume

37

Location

Minneapolis, MN

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Conference Name

American-Heart-Association's Arteriosclerosis, Thrombosis and Vascular Biology/Peripheral Vascular Disease Scientific Sessions

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology